Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.35 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5545676 | 0.85 | SLC6A2 (0.36) | HTTSLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL5550392 | 0.85 | HTT (0.36) | HTTSMN1; SMN2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5549258 | 0.83 | HTT (0.38) | HTTSLC6A2SLC6A4 | |
| SCHEMBL11953999 | 0.70 | CHRNB2 (0.42) | SMN1; SMN2SLC6A2SLC6A4SLC6A3HRH1 | |
| SCHEMBL3386535 | 0.68 | TAAR1 (0.41) | SLC6A2SLC6A4SLC6A3CHRNB2CHRNA4 | |
| SCHEMBL3386613 | 0.68 | TAAR1 (0.41) | SLC6A2SLC6A4SLC6A3CHRNB2CHRNA4 | |
| SCHEMBL3386536 | 0.68 | TAAR1 (0.41) | SLC6A2SLC6A4SLC6A3CHRNB2CHRNA4 | |
| SCHEMBL7288351 | 0.67 | SCN1A (0.57) | HTTSMN1; SMN2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16767872 | 0.67 | HRH1 (0.48) | SLC6A4SLC6A3HRH1KIF11CHRNB2 | |
| Bromomethane SCHEMBL5569429 | 0.66 | SLC6A2 (0.56) | HTTSMN1; SMN2SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7301018-B2 | Probe for mass spectrometry of liquid sample | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20040142378-A1 | Probe for mass spectrometry of liquid sample | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-07-22 | — | — | US | disclosed |
| US-20040031122-A1 | Wiping device | VALEO WISCHERSYSTEME GMBH (DE) | 2004-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142378-A1 | Probe for mass spectrometry of liquid sample | MRPS22, MRPS27, MRPS23 | HTT 3937/4885SMN1; SMN2 4157/4885SLC6A2 3057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.